(Q50895646)

24 March 2018

title

Clozapine and body mass change. (English)

1 reference

24 March 2018

2

Zanarini MC

1 reference

24 March 2018

Frances Rachel Frankenburg

series ordinal

1

object named as

Frankenburg FR

1 reference

24 March 2018

author name string

Kando J

series ordinal

3

1 reference

24 March 2018

Centorrino F

series ordinal

4

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

24 March 2018

published in

Biological Psychiatry

1 reference

24 March 2018

volume

43

1 reference

24 March 2018

issue

7

1 reference

24 March 2018

page(s)

520-524

1 reference

24 March 2018

Clozapine. A novel antipsychotic agent

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Differential effect of clozapine on weight: a controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Weight gain associated with clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Long-term experience with clozapine in Denmark: research and clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Smoking cessation and weight gain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Weight gain among schizophrenic patients treated with clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Clozapine-induced weight gain: prevalence and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Body weight and mortality. A 27-year follow-up of middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Clozapine in the treatment of 121 out-patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Dopamine and Schizophrenia: A Reappraisal in the Light of Clinical Studies with Clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Tolerability of long term clozapine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Prevalence of obesity in patients receiving depot antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

The distribution of adipose tissue in female in-patients receiving psychotropic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Weight gain with clozapine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

Smoking cessation and severity of weight gain in a national cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900488-5

10.1016/S0006-3223(97)00488-5

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

9547931

1 reference

24 March 2018